Fonar subsidiary purchases MSO
Fonar's physician practice management subsidiary, U.S. Health Management, has purchased a managed service organization (MSO) managing four high-volume primary-care practices in New York City. The practices are expected to add about $2 million to HMC's
Fonar's physician practice management subsidiary, U.S. Health Management, has purchased a managed service organization (MSO) managing four high-volume primary-care practices in New York City. The practices are expected to add about $2 million to HMC's operating profits over the next twelve months, according to Fonar of Melville, NY.
Accounting for over 52,000 patient visits per year, the practices have experienced an annual growth rate of 30% over the past five years and have contracts with several third-party payors and major managed-care organizations, according to Fonar. Fonar president and chairman Dr. Raymond Damadian said he is pleased with the growth of the HMC subsidiary and is encouraged by the potential the expansion offers for future Fonar MRI sales.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
